4 Quarterly tender offers to repurchase shares are targeted at 5.0% of HLEND’s common shares outstanding (by number of shares) per quarter, but not
guaranteed to occur at that level or at all. HLEND’s Board of Trustees may amend or suspend share repurchases at its discretion.
5 Estimated pending final transfer agent processing of tender requests.
6 This information is being provided for illustrative purposes only and is not representative of any investment. While HLEND may seek out an investment
that contains the characteristics described here, there can be no assurances that any such opportunities will be available or that the investments in the actual
portfolio will share any of these characteristics. In addition, there is no guarantee that the trends described herein will continue or that HLEND will be able
to successfully take advantage of these trends.
7 As of April 30, 2026. Percentage based on the aggregate fair value of the investment portfolio as of April 30, 2026. Includes “last out” portions of first
lien senior secured loans. The portion of HLEND’s portfolio invested in first lien senior securities may vary over time.
8 As of April 30, 2026. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in
the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance,
at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets, restructured debt and
equity, investments on non-accrual status as of April 30, 2026, and investments in joint ventures. In the case of weighted average EBITDA only, excludes
investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of
the original investment thesis, such as loan-to-value-based loans, or NAV-based loans. Weighted average EBITDA is weighted based on the fair value of
the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an
investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the
fair value of the total applicable level 3 debt investments. Figures are derived from the most recent financial statements from portfolio companies.
9 Represents LTM revenue/EBITDA growth in HLEND’s private portfolio using the latest financials available as of March 31, 2026. Calculated with
respect to all level 3 investments in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment
adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees) as of March 31,
2026, and excludes quoted assets, restructured debt and equity, investments on non-accrual status as of March 31, 2026, and investments in joint ventures.
Excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material
component of the original investment thesis, such as loan-to-value-based loans and NAV-based loans. Weighted based on the fair value of the total
applicable level 3 investments. Figures are derived from the most recent financial statements from portfolio companies. Excludes companies with a year-
over-year reporting period of less than twelve months.
10 Interest coverage ratio of the investment portfolio, determined on a weighted average basis with respect to the applicable level 3 debt investments (as
described below), and weighted based on the fair value of such level 3 debt investments, is estimated as the ratio of average last-twelve-month EBITDA
(“LTM EBITDA”) to cash interest based on the borrowing levels and market rates as of January 31, 2026 with respect to each level 3 debt investment in
the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the Investment Adviser of HLEND, with
assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets, restructured
debt and equity, investments on non-accrual status as of March 31, 2026, and investments in joint ventures as well as investments with no reported
EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis,
such as loan-to-value based loans and NAV-based loans. Portfolio company credit statistics for HLEND are derived from the most recently available
portfolio company financial statements as of March 31, 2026, have not been independently verified by HLEND, may reflect a normalized or adjusted
amount, and are generally about 90 days in arrears. Accordingly, HLEND makes no representation or warranty in respect of this information. EBITDA is a
non-GAAP financial measure. For a particular portfolio company, LTM EBITDA is generally defined as net income before net interest expense, income
tax expense, depreciation and amortization over the preceding 12-month period.
11 Debt to equity ratio as of April 30, 2026.
12 Reflects the amount of undrawn capacity across the revolving credit facilities.
13 Represents the sum of cash and cash equivalents.
14 Based on fair market value of level 2 assets.
15 Estimated based on (i) subscriptions for the January 1, 2026, February 1, 2026, March 1, 2026, April 1, 2026, May 1, 2026, and June 1, 2026
subscription dates, (ii) shares acquired via the distribution reinvestment program (“DRIP”) associated with distributions paid or expected to be paid during
the first and second quarters of 2026, and (iii) shares repurchased or expected to be repurchased as of March 31, 2026 and June 30, 2026. DRIP proceeds
for the June 1, 2026 reinvestment date are estimated and subject to final confirmation. Share repurchases as of June 30, 2026 are estimated as
approximately $620 million, or 5% of shares outstanding as of March 31, 2026 (using the NAV per share as of April 30, 2026).
16 Represents the figures attributable to Class S if Class S commenced operations at the same time as Class F, Class D and Class I. For the avoidance of
doubt, Class S commenced operations on October 1, 2023 and the figures attributed to Class S for the inception-to-date annualized total net